172 related articles for article (PubMed ID: 22304571)
21. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
23. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population.
Zhang J; Li Y; Wang R; Wen D; Sarbia M; Kuang G; Wu M; Wei L; He M; Zhang L; Wang S
Int J Cancer; 2003 Jun; 105(2):281-4. PubMed ID: 12673692
[TBL] [Abstract][Full Text] [Related]
24. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
[TBL] [Abstract][Full Text] [Related]
25. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
28. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
30. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Wang S; Huang Y; Su R; Fang Z; Han M
Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
[TBL] [Abstract][Full Text] [Related]
32. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
33. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and
Salimi S; Shahrakipour M; Hajizadeh A; Mokhtari M; Mousavi M; Teimoori B; Yaghmaei M
Biomed Rep; 2017 Feb; 6(2):237-241. PubMed ID: 28357079
[TBL] [Abstract][Full Text] [Related]
35. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.
El Menshawy N; El Marghany AB; Sarhan MM; Aladle DA
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2941-2947. PubMed ID: 33112552
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
[TBL] [Abstract][Full Text] [Related]
38. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.
Gupta VK; Feber A; Xi L; Pennathur A; Wu M; Luketich JD; Godfrey TE
Clin Cancer Res; 2008 Dec; 14(23):7804-12. PubMed ID: 19047108
[TBL] [Abstract][Full Text] [Related]
39. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
Meng Y; Zhang C; Zhou X
Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
[TBL] [Abstract][Full Text] [Related]
40. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]